A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether alpha-tocopherol, memantine (Namenda), or
the combination will significantly delay clinical progression in mild to moderately demented
patients with Alzheimer's disease compared to placebo.
Phase:
Phase 3
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development
Collaborators:
DSM Nutritional Products, Inc. Forest Laboratories
Treatments:
alpha-Tocopherol Memantine Tocopherols Tocotrienols Vitamin E Vitamins